Article
Aldehyde dehydrogenases in acute myeloid leukemia
1 Mar 2014
Abstract excerpt
Acute myeloid leukemia (AML) affects approximately 15,000 persons per year in the United States and is the sixth leading cause of cancer-related deaths. The treatment of AML has advanced little in the past thirty years, in part because of the biologic heterogeneity of the disease and the difficulty in targeting AML cells while sparing normal hematopoietic cells. Advances in preventing and treating AML are likely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
